- $392.28m
- $406.08m
- $1.82m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.3 | 23.9 | 26 | 0.157 | 1.82 |
Cost of Revenue | |||||
Gross Profit | -1.98 | -11.3 | -2.57 | 0.157 | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 47 | 67.7 | 53.8 | 22.5 | 321 |
Operating Profit | -39.7 | -43.8 | -27.8 | -22.4 | -319 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -39.6 | -44.8 | -29.2 | -16.9 | -338 |
Provision for Income Taxes | |||||
Net Income After Taxes | -39.6 | -44.8 | -29.2 | -16.9 | -338 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -39.6 | -44.8 | -29.2 | -16.9 | -268 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -39.6 | -44.8 | -29.2 | -16.9 | -268 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -60.4 | -65.2 | -41 | -18.4 | -10.2 |